Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 5/2011

01-05-2011 | Research Articles

Effectiveness of darbepoetin alfa in a cohort of oncology patients with chemotherapy-induced anaemia. Relationship between variation in three fatigue-specific quality of life questionnaire scores and change in haemoglobin level

Authors: Gaspar Esquerdo, Cristina Llorca, José Manuel Cervera, David Orts, Asunción Juárez, Alfredo Carrato

Published in: Clinical and Translational Oncology | Issue 5/2011

Login to get access
Metadata
Title
Effectiveness of darbepoetin alfa in a cohort of oncology patients with chemotherapy-induced anaemia. Relationship between variation in three fatigue-specific quality of life questionnaire scores and change in haemoglobin level
Authors
Gaspar Esquerdo
Cristina Llorca
José Manuel Cervera
David Orts
Asunción Juárez
Alfredo Carrato
Publication date
01-05-2011
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 5/2011
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-011-0664-3

Other articles of this Issue 5/2011

Clinical and Translational Oncology 5/2011 Go to the issue

Research Articles

HER2 status in breast cancer: experience of a Spanish National Reference Centre

Research Articles

Management of lung cancer-associated anaemia: the Spanish Lung Cancer Anaemia Survey (SLCAS)

Editorial

Erythropoiesis-stimulating agents: the present situation

Educational Series

New DNA sequencing technologies open a promising era for cancer research and treatment

Reviews

Therapeutic interventions targeting organ preservation in muscle-invasive bladder cancer: a review

Research Articles

Evaluation of ototoxicity in children treated for retinoblastoma: preliminary results of a systematic audiological evaluation
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits